UCB signs $2bn worth deal with Roche for AD drug candidate UCB0107
Belgian pharma company UCB has signed a global exclusive license deal worth up to $2 billion for its Alzheimer's Disease drug candidate (AD drug candidate) ... Read More
AXA to sell AXA Bank Belgium to Crelan Bank for €620m
French insurance giant AXA has signed a €620 million deal to sell AXA Bank Belgium, its Belgian banking operations, to Crelan Bank, a Belgium-based cooperative ... Read More
TransPerfect acquires Belgian entertainment company Lylo Media Group
TransPerfect, a provider of language and technology solutions, has acquired Lylo Media Group, a Belgium-based provider of dubbing, voiceover, audio description, subtitling, and hard-of-hearing services, ... Read More
Fluxys and Snam to buy out CDPQ’s stake in Interconnector UK pipeline
Oil and gas industry news : Fluxys and Snam will buy out the 33.5% stake of Canadian pension fund Caisse de depot et placement du ... Read More
Sanofi to acquire Belgian biotech firm Ablynx for €3.9bn in all-cash deal
French pharmaceutical giant Sanofi has successfully finalized an agreement to acquire Ablynx, a Belgian biotechnology firm, for approximately €3.9 billion. This strategic acquisition surpasses a ... Read More
Takeda Pharmaceutical set to acquire TiGenix for €520m, enhancing gastroenterology and specialty care offerings
Japanese pharmaceutical giant Takeda Pharmaceutical has announced a proposal to acquire TiGenix, a Belgium-based cell therapy company, for €520 million. This acquisition is aimed at ... Read More